Vytrus Biotech, S.A. (BME:VYT)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Plant Stem Cells	3.55M
Plant Stem Cells Growth	113.60%
Plant Stem Cells Services	184.99K
Plant Stem Cells Services Growth	340.46%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Spain	1.47M
Spain Growth	86.59%
International	1.18M
International Growth	28.48%
European Union	1.09M